A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen
Public ClinicalTrials.gov record NCT00769067. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase 2 Trial Of Pf-00299804 Versus Erlotinib For The Treatment Of Advanced Non-small Cell Lung Cancer After Failure Of At Least One Prior Chemotherapy Regimen
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare PF-00299804 given orally on continuous schedule to the approved drug, erlotinib, in patients whose non-small cell lung cancer has progressed after chemotherapy; patients will be randomized to receive one of these drugs, and followed for efficacy and tolerance of each.
Study identification
- NCT ID
- NCT00769067
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 188 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2008 (Type not available)
- Primary completion
- Oct 2010 (Actual)
- Completion
- Aug 2014 (Actual)
- Last update posted
- Oct 7, 2015
2008 – 2014
United States locations
- U.S. sites
- 26
- U.S. states
- 10
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Alabama Cancer Center | Muscle Shoals | Alabama | 35661 | — |
| Agajanian Institute of Oncology and Hematology | Montebello | California | 90640 | — |
| Bridgeport Hospital | Bridgeport | Connecticut | 06610 | — |
| Wittingham Cancer Center @ Norwalk Hospital | Norwalk | Connecticut | 06856 | — |
| Medical Oncology & Hematology, P.C. | Waterbury | Connecticut | 06708 | — |
| Winship Cancer Institute at Grady Health Systems | Atlanta | Georgia | 30303 | — |
| Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322-1013 | — |
| Winship Cancer Institute at Emory University | Atlanta | Georgia | 30322 | — |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | — |
| Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322 | — |
| Augusta Oncology Associates, P.C. | Augusta | Georgia | 30901 | — |
| Augusta Oncology Associates, PC | Augusta | Georgia | 30909 | — |
| John B. Amos Cancer Center | Columbus | Georgia | 31904 | — |
| Georgia Cancer Specialists | Decatur | Georgia | 30033 | — |
| The Longstreet Cancer Center | Gainesville | Georgia | 30501 | — |
| Central Georgia Cancer Care, P.C. | Macon | Georgia | 31201 | — |
| Northwest Georgia Oncology Center | Marietta | Georgia | 30106 | — |
| Central Georgia Cancer Care, P.C. | Warner Robins | Georgia | 31088-2259 | — |
| Kootenai Cancer Center at Post Falls | Post Falls | Idaho | 83854 | — |
| Kootenai Cancer Center | Post Falls | Idaho | 83854 | — |
| Midwestern Regional Medical Center | Zion | Illinois | 60099 | — |
| Center for Blood and Cancer Disorders | Bethesda | Maryland | 20817 | — |
| Associates in Oncology/Hematology, PC | Rockville | Maryland | 20850 | — |
| University of Minnesota Cancer Center | Minneapolis | Minnesota | 55455 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
| Oncology/Hematology Associates | Clarksburg | West Virginia | 26301 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00769067, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 7, 2015 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00769067 live on ClinicalTrials.gov.